• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships.

作者信息

Benbrook D M, Subramanian S, Gale J B, Liu S, Brown C W, Boehm M F, Berlin K D

机构信息

Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, PO Box 26901, WP2470, Oklahoma City, Oklahoma 73190, USA.

出版信息

J Med Chem. 1998 Sep 10;41(19):3753-7. doi: 10.1021/jm980308p.

DOI:10.1021/jm980308p
PMID:9733501
Abstract

Heteroarotinoids are synthetic retinoids derived from trans-retinoic acid and the arotinoid structures and include a heteroatom in a five- or six-membered cyclic ring. This is the first systematic study of influences of the heteroatom, ring size, number of aryl groups, and terminal side chain on retinoid receptor specificity. Two new heteroarotinoids were synthesized and characterized. Although all heteroarotinoids activated RAR receptors, two dominant associations between structure and specificity were identified across all compounds. The six-membered ring conferred increased RARbeta specificity over the five-membered ring. The sulfur atom conferred greater specificity for RARgamma than the oxygen atom. RARalpha specificity was attenuated by a combination of influences from the heteroatom and aryl groups. In summary, the heteroatom and cyclic ring size exerted dominant effects, while the number of aryl rings and terminal side chain had attenuating effects on retinoid receptor specificity of heteroarotinoids.

摘要

相似文献

1
Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships.
J Med Chem. 1998 Sep 10;41(19):3753-7. doi: 10.1021/jm980308p.
2
Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.氮杂芳维甲酸类化合物的合成、构效关系及与视黄酸受体γ的相互作用
J Med Chem. 1999 Sep 9;42(18):3602-14. doi: 10.1021/jm9900974.
3
Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.可诱导细胞凋亡和活性氧生成且能区分恶性细胞与良性细胞的柔性含硫杂阿罗他汀类化合物的合成。
J Med Chem. 2004 Feb 12;47(4):999-1007. doi: 10.1021/jm030346v.
4
Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.杂芳维甲酸类化合物通过RAR和RXR视黄酸受体在体外和体内抑制头颈癌细胞系。
J Med Chem. 1999 Oct 21;42(21):4434-45. doi: 10.1021/jm990292i.
5
Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.人类视黄酸核受体同种型选择性的结构基础。
J Mol Biol. 2000 Sep 8;302(1):155-70. doi: 10.1006/jmbi.2000.4032.
6
Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.具有抗癌活性且毒性降低的生物活性杂芳维甲酸类化合物。
J Med Chem. 1997 Oct 24;40(22):3567-83. doi: 10.1021/jm970196m.
7
Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.对类视黄醇和类视黄醇X受体具有反向激动剂活性的吡嗪芳维A酸类化合物。
Chembiochem. 2009 May 4;10(7):1252-9. doi: 10.1002/cbic.200900030.
8
Identification of the first retinoid X, receptor homodimer antagonist.首个视黄酸X受体同二聚体拮抗剂的鉴定。
J Med Chem. 1996 Aug 16;39(17):3229-34. doi: 10.1021/jm960311d.
9
Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.维甲酸受体亚型选择性激动剂和拮抗剂工程化的结构基础。
Chem Biol. 1999 Aug;6(8):519-29. doi: 10.1016/S1074-5521(99)80084-2.
10
Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.维甲酸受体功能的调节改变了口腔鳞状细胞癌(SCC)细胞对维甲酸的生长抑制反应。
Oncogene. 2000 Mar 9;19(11):1457-65. doi: 10.1038/sj.onc.1203436.

引用本文的文献

1
SHetA2 Attack on Mortalin and Colleagues in Cancer Therapy and Prevention.SHetA2在癌症治疗与预防中对mortalin及相关蛋白的作用
Front Cell Dev Biol. 2022 Feb 23;10:848682. doi: 10.3389/fcell.2022.848682. eCollection 2022.
2
Retinoids: novel immunomodulators and tumour-suppressive agents?类视黄醇:新型免疫调节剂和肿瘤抑制因子?
Br J Pharmacol. 2012 Oct;167(3):483-92. doi: 10.1111/j.1476-5381.2012.02031.x.
3
Novel retinoic acid receptor alpha agonists for treatment of kidney disease.新型维 A 酸受体 α 激动剂治疗肾脏疾病。
PLoS One. 2011;6(11):e27945. doi: 10.1371/journal.pone.0027945. Epub 2011 Nov 18.
4
Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.驱动子宫内膜癌发生和化学预防器官型模型的生物系统的基因表达分析。
Gene Regul Syst Bio. 2008;2:21-42. doi: 10.4137/grsb.s344.
5
Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo.柔性杂芳维甲酸(Flex-Het)SHetA2在体内外均能抑制血管生成。
Invest New Drugs. 2009 Aug;27(4):304-18. doi: 10.1007/s10637-008-9175-7. Epub 2008 Sep 18.
6
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.与维甲酸受体激动剂相比,柔性杂芳维甲酸类化合物(Flex-Hets)作为抗癌药物具有更高的治疗指数。
Invest New Drugs. 2005 Oct;23(5):417-28. doi: 10.1007/s10637-005-2901-5.
7
Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis.维甲酸受体而非维甲酸X受体的类视黄醇激活足以挽救维甲酸合成中的致命缺陷。
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7135-40. doi: 10.1073/pnas.1231422100. Epub 2003 Jun 2.